tradingswift

Gossamer Bio long

Long
NASDAQ:GOSS   Gossamer Bio, Inc.
Gossamer Bio
Healthcare
Biotechnology
USA
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States and is headquartered in San Diego, California.

- High volume in stock
- Crossed 200 EMA
- Next earnings date - 10 Aug 2022

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.